Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel thiazole derivatives incorporating phenyl sulphonyl moiety as potent BRAFV600E kinase inhibitors targeting melanoma
Afaf Y. Khormi, Thoraya A. Farghaly, Abrar Bayazeed, et al.
RSC Advances (2022) Vol. 12, Iss. 42, pp. 27355-27369
Open Access | Times Cited: 10

Showing 10 citing articles:

Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)
Iryna Ivasechko, Andrii Lozynskyi, Julia Senkiv, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115304-115304
Open Access | Times Cited: 16
Comprehensive study for synthesis, antiviral activity, docking and ADME study for the new fluorinated hydrazonal and indeno[1,2-b]pyridine derivatives
Refaie M. Kassab, Mona H. Ibrahim, Areej Rushdi, et al.
Journal of Molecular Structure (2024) Vol. 1305, pp. 137752-137752
Closed Access | Times Cited: 5
Discovery of novel benzimidazole derivatives as potent HDACs inhibitors against leukemia with (Thio)Hydantoin as zinc-binding moiety: Design, synthesis, enzyme inhibition, and cellular mechanistic study
Hanan Gaber Abdulwahab, Reda El‐Sayed Mansour, Thoraya A. Farghaly, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107284-107284
Closed Access | Times Cited: 3
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 7
The anti-breast cancer activity of indeno[1,2-b]pyridin-5-one and their hydrazonal precursors endowed with anti-CDK-2 enzyme activity
Sami A. Al‐Hussain, Thoraya A. Farghaly, Mona H. Ibrahim, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136692-136692
Closed Access | Times Cited: 7
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 6
Design, and synthesis of selectively anticancer 4-cyanophenyl substituted thiazol-2-ylhydrazones
Hasnain Mehmood, Mustapha Musa, Simon Woodward, et al.
RSC Advances (2022) Vol. 12, Iss. 52, pp. 34126-34141
Open Access | Times Cited: 8
Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity
Thoraya A. Farghaly, Ghada S. Masaret, Hanan Gaber Abdulwahab
Polycyclic aromatic compounds (2024), pp. 1-16
Closed Access
Recent studies on protein kinase signaling inhibitors based on thiazoles: review to date
Manal S. Ebaid, Hoda Atef Abdelsattar Ibrahim, Asmaa F. Kassem, et al.
RSC Advances (2024) Vol. 14, Iss. 50, pp. 36989-37018
Open Access
Synthesis of New Carbazole–Thiazole Analogues and Evaluating their Anticancer Activity
Mohamed R. Elmorsy, Mariam Eltoukhi, Ahmed A. Fadda, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 9, pp. 8048-8064
Closed Access | Times Cited: 2
Page 1

Scroll to top